ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) will boost the degree or influence of ergotamine by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Acute ergot toxicity characterised by vasospasm and tissue ischemia continues to be connected to coadministration of ritonavirGeneral public wellness challenges connected w